TREM2 regulates BV2 microglia activation and influences corticosterone-induced neuroinflammation in depressive

Jingjing Shi1, Xiaohong Wang1, Chuanyi Kang1

  • 1Department of Psychiatry, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin, Heilongjiang Province 150001, China.

Brain Research
|November 3, 2023
PubMed

Insights

TREM2 protein modulates neuroinflammation in a depression model. Upregulating TREM2 reduces inflammatory factors and may offer a new therapeutic target for depressive disorders.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Depressive disorders involve neuroinflammation and microglial overactivation.
  • TREM2, an immune protein in microglia, influences inflammatory responses.
  • Corticosterone (CORT) is a stress hormone impacting the immune system.

Purpose of the Study:

  • Investigate TREM2's role in CORT-induced BV2 cell damage.
  • Analyze TREM2's effects on the JAK2/STAT3 pathway and microglia polarization.
  • Explore TREM2 as a potential therapeutic target for depression.

Main Methods:

  • Established a cell model of CORT-induced depression in vitro.
  • Utilized CCK8 assay to assess CORT's effect on BV2 cell activity.
  • Employed plasmid transfection for TREM2 overexpression and interference.
  • Analyzed protein and inflammatory factor expression via Western blotting, PCR, and ELISA.

Main Results:

  • CORT affected BV2 cell proliferation and TREM2 levels.
  • TREM2 overexpression reduced TNF-α, IL-1β, IL-6, and increased IL-10.
  • TREM2 interference increased TNF-α, IL-1β, IL-6, and decreased IL-10.
  • TREM2 influenced inflammatory factor release via the JAK2/STAT3 pathway and regulated microglia polarization.

Conclusions:

  • TREM2 plays a critical role in regulating CORT-induced inflammatory responses.
  • TREM2 influences the neuroinflammatory pathogenesis of depressive disorders.
  • TREM2 presents a potential novel therapeutic target for depressive disorders.